Schizophrenia patients are not benefiting from worldwide improvements in life expectancy.

Autor: Llorca-Bofí V; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Plana-Ripoll O; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Bioque M; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: mbioque@clinic.cat.
Jazyk: angličtina
Zdroj: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Aug; Vol. 85, pp. 2. Date of Electronic Publication: 2024 Apr 20.
DOI: 10.1016/j.euroneuro.2024.04.001
Databáze: MEDLINE
Externí odkaz: